Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


BCRP inhibitor
BML-EI396-0005 5 mg 179.00 USD
BML-EI396-0025 25 mg 776.00 USD
Do you need bulk/larger quantities?
Analog of the fungal toxin fumitremorgin C (Prod. No. ALX-350-127). Potent and selective inhibitor of the breast cancer resistance protein multidrug transporter (BCRP, EC90=26nM). Highly effective for increasing the intracellular drug accumulation and reversing BCRP-mediated multidrug resistance yet has little activity against P-glycoprotein, multidrug resistance-associated protein (MRP1) and other known drug transporters. In mouse models Ko143 was able to restore the intracellular accumulation and abolish the directionality in net flux of dasatinib. It is a highly useful tool for the identification of drug transport processes in complex experimental systems.

Product Details

Alternative Name:(3S,6S,12aS)-1,2,3,4,6,7,12,12a-Octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxopyrazino-[1',2':1,6]pyrido[3,4-b]indole-3-propanoic acid 1,1-dimethylethyl ester
Purity:≥96% (HPLC)
Appearance:White solid.
Solubility:Soluble in DMSO (>25mg/ml) or 100% ethanol (>25mg/ml).
Long Term Storage:-20°C
Use/Stability:Store solutions at -20°C for up to 3 months.
Regulatory Status:RUO - Research Use Only
Please mouse over

Product Literature References

ABCB1 as a potential beneficial target of midostaurin in acute myeloid leukemia: S. Sucha, et al.; Biomed. Pharmacother. 150, 112962 (2022), Abstract;
Folium Sennae Increased the Bioavailability of Methotrexate through Modulation on MRP 2 and BCRP: C.P. Yu, et al.; Pharmaceuticals 14, 1036 (2021), Abstract;
Increased Systemic Exposure of Methotrexate by a Polyphenol-Rich Herb via Modulation on Efflux Transporters Multidrug Resistance-Associated Protein 2 and Breast Cancer Resistance Protein: C.P. Yu, et al.; J. Pharm. Sci. 105, 343 (2016), Application(s): Positive inhibitor of BCRP, Abstract;
Dinaciclib, a cyclin-dependent kinase inhibitor, is a substrate of human ABCB1 and ABCG2 and an inhibitor of human ABCC1 in vitro: D. Cihalova, et al.; Biochem. Pharmacol. 98, 465 (2015), Application(s): MDCKII monolayer transport assay, Abstract;
Influence of drug transporters and stereoselectivity on the brain penetration of pioglitazone as a potential medicine against Alzheimer's disease: K.L. Chang, et al.; Sci. Rep. 5, 9000 (2015), Application(s): Cell Culture, Abstract; Full Text
ABC transporter activity linked to radiation resistance and molecular subtype in pediatric medulloblastoma: W.J. Ingram, et al.; Exp. Hematol. Oncol. 2, 26 (2013), Abstract; Full Text
Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs: P. Matsson, et al.; Pharm. Res. 26, 1816 (2009), Abstract;
P-glycoprotein and breast cancer resistance protein influence brain distribution of dasatinib: Y. Chen, et al.; J. Pharmacol. Exp. Ther. 330, 956 (2009), Abstract;
Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C: J.D. Allen, et al.; Mol. Cancer Ther. 1, 417 (2002), Abstract;

Related Literature

Product Flyers
Detect Activity of Major ABC Transporter Proteins
Detect Activity of Major ABC Transporter Proteins
Download as PDF

Stem Cells
Stem Cells
Download as PDF

All new literature pieces